South & Central America Organoids Market Forecast to 2030
South & Central America Organoids Market Forecast to 2030 – Regional Analysis – by Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), and Type (Instruments, Consumables, and Services)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Focus on Drug Discovery Activities Fuel South & Central America Organoids Market
The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.
Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ’s original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study ‘CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,’ published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids’ safety, long-term stability, and functionality.
Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.
South & Central America Organoids Market Overview
The South & Central America organoids market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for organoids.
South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Organoids Market Segmentation
The South & Central America organoids market is segmented into organ type, type, application, Source, and country.
Based on organ type, the South & Central America organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the South & Central America organoids market in 2022.
Based on type, the South & Central America organoid market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the North America organoid market in 2022.
Based on application, the South & Central America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the South & Central America organoids market in 2022.
Based on source, the South & Central America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held the larger share of the South & Central America organoids market in 2022.
Based on country, the South & Central America organoids market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America organoids market in 2022.
Cellesce, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc, are some of the leading companies operating in the South & Central America organoids market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the South & Central America Organoids market was valued at US$ 132.38 million in 2022 and is expected to reach US$ 654.25 million by 2030, registering a CAGR of 22.1% from 2022 to 2030. Combining organoid with organ-on-a-chip is the critical factor attributed to the South & Central America Organoids market expansion.
Organoid and organ-on-a-chip, which serve as evolving pathological and human physiological relevant in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit benefits of both organoid and organ-on-a-chip and provide a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.
In addition, technological advancements will facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening by combining organoids with organ-on-a-chip. Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, and more. Although organoid-on-a-chip is currently a developing field, much scope exists for improvement. Thus, it will also require cooperative efforts from interdisciplinary researchers to reach organoids’ full utility in human biomedical studies and lead the market’s growth in the coming future.
On the contrary, issues related to incorporation of organoids into existing workflows and dearth of skilled professionals hampers the South & Central America organoids market.
Based on organ type, the South & Central America organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held 23.0% share of South & Central America organoids market in 2022, amassing US$ 30.49 million. It is projected to garner US$ 147.92 million by 2030 to expand at 21.8% CAGR during 2022–2030.
Based on application, the South & Central America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held 29.7% share of South & Central America organoids market in 2022, amassing US$ 39.36 million. It is projected to garner US$ 203.58 million by 2030 to expand at 22.8% CAGR during 2022–2030.
Based on source, the South & Central America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held 71.9% share of South & Central America organoids market in 2022, amassing US$ 95.16 million. It is projected to garner US$ 485.25 million by 2030 to expand at 22.6% CAGR during 2022–2030.
Based on type, the South & Central America organoids market is segmented into instruments, consumables, and services. The consumables segment held 61.0% share of South & Central America organoids market in 2022, amassing US$ 80.78 million. It is projected to garner US$ 419.35 million by 2030 to expand at 22.9% CAGR during 2022–2030.
Based on country, the South & Central America organoids market has been categorized into the Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 65.9% share of South & Central America organoids market in 2022. It was assessed at US$ 87.29 million in 2023 and is likely to hit US$ 439.53 million by 2030, exhibiting a CAGR of 22.4% during 2022–2030.
Key players operating in the South & Central America organoids market are Cellesce, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc, among others.
In Feb 2023, the collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the unmet market need for high-throughput automated cell line culturing and maintenance.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America organoids market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South America organoids market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South America market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 South & Central America Key Insights
2.2 South & Central America Market Attractiveness
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Organoids Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
5. South & Central America Organoids Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:
6. Organoids Market – South & Central America Market Analysis
6.1 South & Central America Organoids Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Organoids Market – Revenue and Forecast to 2030 – by Organ Type.
7.1 Overview
7.2 South & Central America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Organoids Market – Revenue and Forecast to 2030 – by Application.
8.1 Overview
8.2 South & Central America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Organoids Market – Revenue and Forecast to 2030 – by Source.
9.1 Overview
9.2 South & Central America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Organoids Market – Revenue and Forecast to 2030 – by Type
10.1 Overview
10.2 South & Central America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
10.3 Instruments
10.3.1 Overview
10.3.2 Instruments: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Consumables
10.4.1 Overview
10.4.2 Consumables: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Services
10.5.1 Overview
10.5.2 Services: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Organoids Market – Country Analysis
11.1 South & Central America Organoids Market: Overview
11.1.1 South & Central America Organoids Market by Country
11.1.1.1 Brazil
11.1.1.1.1 Overview
11.1.1.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 Brazil Organoids Market, by Organ Type
11.1.1.1.4 Brazil Organoids Market, by Application
11.1.1.1.5 Brazil Organoids Market, by Source
11.1.1.1.6 Brazil Organoids Market, by Type
11.1.1.2 Argentina
11.1.1.2.1 Overview
11.1.1.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Argentina Organoids Market, by Organ Type
11.1.1.2.4 Argentina Organoids Market, by Application
11.1.1.2.5 Argentina Organoids Market, by Source
11.1.1.2.6 Argentina Organoids Market, by Type
11.1.1.3 Rest of South & Central America
11.1.1.3.1 Overview
11.1.1.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 Rest of South & Central America Organoids Market, by Organ Type
11.1.1.3.4 Rest of South & Central America Organoids Market, by Application
11.1.1.3.5 Rest of South & Central America Organoids Market, by Source
11.1.1.3.6 Rest of South & Central America Organoids Market, by Type
12. Pre & Post COVID-19 Impact
12.1 Pre & Post COVID-19 Impact
13. South & Central America Organoids Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. South & Central America Organoids Market, Key Company Profiles
14.1 STEMCELL Technologies Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Cellesce Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 InSphero
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Organoids Market Segmentation
Table 2. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 3. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 4. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 5. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 6. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 7. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 8. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 9. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 10. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 11. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 12. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 13. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms, South & Central America Organoids Market
LIST OF FIGURES
Figure 1. South & Central America Organoids Market Segmentation, By Country
Figure 2. South & Central America – PEST Analysis
Figure 3. South & Central America Organoids Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. South & Central America Organoids Market Revenue (US$ Mn), 2022 – 2030
Figure 6. South & Central America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
Figure 7. Stomach: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Intestine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Liver: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Pancreas: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Lung: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Brain: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Kidney: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Developmental Biology: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Disease Pathology of Infectious Disease: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Regenerative Medicine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Drug Discovery and Personalized Medicine: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
Figure 23. Pluripotent Stem Cells: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Organ-specific Adult Stem Cells: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
Figure 26. Instruments: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Consumables: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Services: South & Central America Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Organoids Market, By Country – Revenue (2022) ($Mn)
Figure 30. South & Central America Organoids Market, By Key Countries, 2022 and 2030 (%)
Figure 31. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Pre & Post COVID-19 Impact
Figure 35. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies – South & Central America Organoids Market
o Cellesce
o InSphero
o Merck KGaA
o STEMCELL Technologies Inc
o Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.